tirzepatide for anxiety not linked to increased risk depression Does Tirzepatide Make You Quiet?

The American Diabetes Association 2024 Standards of Care caution that GLP-1 use in type 1 requires specialist endocrinology co-management

Pinkerton, J

Retatrutide (LY3437943) is a triple receptor agonist acting on the GLP-1, GIP, and glucagon receptors, studied in metabolic and obesity research for its effects on energy expenditure, glucose regulation and body composition

All GLP-1 medications have been proven to be effective for diabetes, and some have been studied and proven to be effective for weight loss as well

Additional genetic markers affecting medication response include variants in the FTO and MC4R genes, which regulate appetite signaling and metabolic rate